|
Volumn 373, Issue 9668, 2009, Pages 1007-1008
|
Atypical antipsychotic drugs have their merits - Authors' reply
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATYPICAL ANTIPSYCHOTIC AGENT;
CLOZAPINE;
PERPHENAZINE;
NEUROLEPTIC AGENT;
SEROTONIN ANTAGONIST;
DRUG RESEARCH;
DYSKINESIA;
HUMAN;
LETTER;
PRIORITY JOURNAL;
SCHIZOPHRENIA;
TARDIVE DYSKINESIA;
CLASSIFICATION;
NOTE;
PSYCHOSIS;
RANDOMIZED CONTROLLED TRIAL;
ANTIPSYCHOTIC AGENTS;
CLOZAPINE;
HUMANS;
PSYCHOTIC DISORDERS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
SEROTONIN ANTAGONISTS;
|
EID: 62349106534
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(09)60607-3 Document Type: Letter |
Times cited : (1)
|
References (5)
|